RADX

Radiopharm Theranostics (RADX)

About Radiopharm Theranostics (RADX)

Radiopharm Theranostics Ltd. operates as a pre-clinical and clinical research company. It focuses on the development of radiopharmaceutical products for diagnostic and therapeutic uses in areas of high unmet medical need. The company is founded by Paul A. Hopper in 2021 headquartered Carlton, Australia.

Details

Daily high

$6.45

Daily low

$5.60

Price at open

$6.36

52 Week High

$16.25

52 Week Low

$3.50

Market cap

125.6M

Dividend yield

0.00%

Volume

2.8M

Avg. volume

2.0M

P/E ratio

-3.06

Radiopharm Theranostics News